CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Baltimore, Maryland, United States and 89 other locations
and ibrutinib in patients with previously treated mantle cell lymphoma to evaluate the efficacy of this combination, with the primary object...
Phase 2
Baltimore, Maryland, United States and 8 other locations
pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma...
Phase 1
Baltimore, Maryland, United States and 12 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Fairfax, Virginia, United States and 40 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Columbia, Maryland, United States and 71 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Columbia, Maryland, United States and 103 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Baltimore, Maryland, United States and 75 other locations
Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...
Phase 1
Fairfax, Virginia, United States and 9 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Baltimore, Maryland, United States and 215 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Baltimore, Maryland, United States and 67 other locations
Clinical trials
Research sites
Resources
Legal